These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Studies on butazolidine and irgapyrin in their relation to agranulocytosis]. VON RECHENBERG HK Acta Haematol; 1953 Jun; 9(6):354-69. PubMed ID: 13079570 [No Abstract] [Full Text] [Related]
8. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
9. [Agranulocytosis from phenylbutazone with the presence of autoantibodies in the blood]. MAZARE ; RONOT Lyon Med; 1957 Dec; 89(48):597-603. PubMed ID: 13515514 [No Abstract] [Full Text] [Related]
10. [Two cases of agranulocytosis due to phenylbutazone]. ZUCCONI V; BALESTRA F Rass Giuliana Med; 1958 Oct; 14(10):180-2. PubMed ID: 13624079 [No Abstract] [Full Text] [Related]
11. [Case of agranulocytosis following butadione therapy of rheumatic heart disease]. TARANENKO AF Probl Gematol Pereliv Krovi; 1959 May; 4(5):48-50. PubMed ID: 13658107 [No Abstract] [Full Text] [Related]
12. [Protective effect of ascorbic acid in drug-induced experimental & clinical peptic ulcers, especially by butazolidine]. ARON E Therapie; 1958; 13(2):185-90. PubMed ID: 13556694 [No Abstract] [Full Text] [Related]
13. [Therapeutic complication caused by phenylbutazone (arterial thrombosis, gangrene, agranulocytosis, plasmocytosis)]. LENG-LEVY J; DAVID-CHAUSSE J; DU PASQUIER R; SERRES A; VEAUX R; BALDENBERGER R J Med Bord; 1959 May; 136(5):598-610. PubMed ID: 13665216 [No Abstract] [Full Text] [Related]
14. [Drug-induced agranulocytosis with medularry plasmacytosis and hyperglobulinemia]. Alcoba Leza M Rev Clin Esp; 1966 Nov; 103(4):316-21. PubMed ID: 5999585 [No Abstract] [Full Text] [Related]
15. [Irgapyrin therapy and agranulocytosis]. ARSLAN A Turk Tip Cemiy Mecm; 1957 Apr; 23(4):200-8. PubMed ID: 13496280 [No Abstract] [Full Text] [Related]